
Co-Diagnostics CODX
€ 1.41
-1.2%
Geschäftsbericht 2025
hinzugefügt 31.03.2026
Co-Diagnostics Langfristiger Schuldenstrom 2011-2026 | CODX
Langfristiger Schuldenstrom Jährlich Co-Diagnostics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 662 K | 916 K | 838 K | 297 K | - | - | - | 1.91 M | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 1.91 M | 297 K | 924 K |
Langfristiger Schuldenstrom anderer Aktien in der Diagnostik & Forschung
| Name | Langfristiger Schuldenstrom | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
2.18 M | - | -6.23 % | $ 30.6 M | ||
|
Akumin
AKU
|
17.2 M | - | -17.87 % | $ 25.9 M | ||
|
Accelerate Diagnostics
AXDX
|
829 K | - | -61.36 % | $ 2.46 M | ||
|
Illumina
ILMN
|
79 M | $ 127.85 | -0.03 % | $ 20.3 B | ||
|
Aspira Women's Health
AWH
|
202 K | - | -6.19 % | $ 10.5 M | ||
|
Lantheus Holdings
LNTH
|
3.8 M | $ 84.13 | -0.24 % | $ 5.68 B | ||
|
Biocept
BIOC
|
518 K | - | -13.05 % | $ 7.29 M | ||
|
Castle Biosciences
CSTL
|
1.66 M | $ 25.25 | 3.23 % | $ 701 M | ||
|
Medpace Holdings
MEDP
|
23.2 M | $ 415.77 | 1.2 % | $ 12 B | ||
|
Chembio Diagnostics
CEMI
|
915 K | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
264 K | - | - | $ 9.42 M | ||
|
Koninklijke Philips N.V.
PHG
|
241 M | $ 27.49 | 0.07 % | $ 20 B | ||
|
CareDx, Inc
CDNA
|
6.52 M | $ 21.59 | 1.67 % | $ 1.15 B | ||
|
Senseonics Holdings
SENS
|
496 K | $ 7.05 | -0.07 % | $ 294 M | ||
|
DermTech
DMTK
|
3.07 M | - | -11.32 % | $ 2.94 M | ||
|
Soleno Therapeutics
SLNO
|
726 K | $ 52.73 | 0.01 % | $ 2.68 B | ||
|
Enzo Biochem
ENZ
|
841 K | - | -8.98 % | $ 14.8 K | ||
|
Exact Sciences Corporation
EXAS
|
33.6 M | - | - | $ 19.8 B | ||
|
Fulgent Genetics
FLGT
|
1.44 M | $ 16.04 | -1.67 % | $ 485 M | ||
|
Global Cord Blood Corporation
CO
|
147 K | - | - | $ 399 M | ||
|
Genetic Technologies Limited
GENE
|
264 K | - | - | $ 7.1 B | ||
|
Thermo Fisher Scientific
TMO
|
275 M | $ 470.4 | 0.18 % | $ 177 B | ||
|
Genetron Holdings Limited
GTH
|
21.5 M | - | 0.12 % | $ 80.1 M | ||
|
Charles River Laboratories International
CRL
|
57.7 M | $ 172.63 | 1.68 % | $ 8.56 B | ||
|
Twist Bioscience Corporation
TWST
|
13.8 M | $ 60.26 | -1.17 % | $ 3.6 B | ||
|
Guardant Health
GH
|
27.7 M | $ 90.75 | 2.07 % | $ 11.4 B | ||
|
HTG Molecular Diagnostics
HTGM
|
475 K | - | -20.0 % | $ 1.06 M | ||
|
Heska Corporation
HSKA
|
2.94 M | - | - | $ 1.31 B | ||
|
Interpace Biosciences
IDXG
|
431 K | $ 2.0 | 1.27 % | $ 8.85 M | ||
|
Motus GI Holdings
MOTS
|
169 K | - | -34.28 % | $ 263 K | ||
|
QIAGEN N.V.
QGEN
|
23.4 M | - | - | $ 10.6 B | ||
|
Neogen Corporation
NEOG
|
5.64 M | $ 9.53 | -0.16 % | $ 2.07 B | ||
|
Biomerica
BMRA
|
358 K | $ 2.16 | 0.93 % | $ 4.96 M | ||
|
National Research Corporation
NRC
|
451 K | $ 17.26 | 0.15 % | $ 386 M | ||
|
ICON Public Limited Company
ICLR
|
24.3 M | $ 101.26 | -0.89 % | $ 8.35 B | ||
|
Laboratory Corporation of America Holdings
LH
|
191 M | $ 264.04 | 0.09 % | $ 22 B | ||
|
Celcuity
CELC
|
54 K | $ 123.49 | 2.03 % | $ 5.77 B | ||
|
OpGen
OPGN
|
174 K | - | -16.95 % | $ 1.54 M | ||
|
NeoGenomics
NEO
|
4.78 M | $ 8.49 | 2.35 % | $ 1.09 B | ||
|
Myriad Genetics
MYGN
|
6.9 M | $ 4.77 | -0.21 % | $ 442 M | ||
|
Natera
NTRA
|
7.64 M | $ 206.37 | 1.29 % | $ 20.3 B | ||
|
Quest Diagnostics Incorporated
DGX
|
174 M | $ 197.48 | 0.62 % | $ 21.9 B | ||
|
Invitae Corporation
NVTA
|
14.6 M | - | - | $ 21.2 M | ||
|
PerkinElmer
PKI
|
589 M | - | -0.91 % | $ 14.7 B |